Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant for Primary Dysmenorrhea
NCT06317064Phase 3Completed
- Sponsor
- Lahore Medical Research Center
- Start
- Mar 2024
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aprepitant in primary dysmenorrhea (PD), sponsored by Lahore Medical Research Center. Started Mar 2024; status: completed.
02
Drugs
aprepitant
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on NCT06317064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06317064.